Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Design and Implementation of High-Throughput Screening Assays

  • Protocol
  • First Online:
High Throughput Screening

Part of the book series: Methods in Molecular Biology ((MIMB,volume 565))

Abstract

HTS is at the core of the drug discovery process, and so it is critical to design and implement HTS assays in a comprehensive fashion involving scientists from the disciplines of biology, chemistry, engineering, and informatics. This requires careful analysis of many variables, starting with the choice of assay target and ending with the discovery of lead compounds. At every step in this process, there are decisions to be made that can greatly impact the outcome of the HTS effort, to the point of making it a success or a failure. Although specific guidelines should be established to ensure that the screening assay reaches an acceptable level of quality, many choices require pragmatism and the ability to compromise opposing forces.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AAO:

automated assay optimization

AAS:

atomic absorbance spectroscopy

BRET:

bioluminescence resonance energy transfer

Bicine:

N,N-bis(2-Hydroxyethyl)glycine

Bmax:

maximum binding capacity

BSA:

bovine serum albumin

CHAPS:

3-([3-Cholamidopropyl]dimethylammonio)-1-propanesulfonate

CV:

coefficient of variation

DMSO:

dimethyl sulfoxide

DTT:

dithiothreitol

ECL:

electrochemiluminescence

EDTA:

ethylenediamine-N,N,N′,N′-tetraacetic acid

EFC:

enzyme fragment complementation

EGTA:

ethylene glycol-bis(2-aminoethyl)-N,N,N′,N′-tetraacetic acid

ELISA:

Enzyme-linked immunosorbent assay

FCS:

fluorescence correlation spectroscopy

FIDA:

fluorescence intensity distribution analysis

FLINT:

fluorescence intensity

FRET:

fluorescence resonance energy transfer

FP:

fluorescence polarization

GPCR:

G protein-coupled receptor

HTS:

high-throughput screening

Kd:

dissociation constant

L:

ligand

M:

mean

NSB:

non specific binding

OD:

optical density unit

PEI:

polyethylene imine

PMSF:

phenylmethylsulfonyl fluoride

RIA:

Radioimmunoassay

S/B:

signal to background ratio

S/N:

signal to noise ratio

SD:

standard deviation

SW:

signal window

SPA:

scintillation proximity assay

TAPS:

N-tris (Hydroxymethyl)methyl-3-aminopropanesulfonic acid

TR-FRET:

time-resolved fluorescence resonance energy transfer

Vmax:

maximum velocity

References

  1. Cascieri MA, Springer MS. (2000) The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention. Curr Opin Chem Biol; 4:420–427.

    Article  CAS  Google Scholar 

  2. Miller WH, Alberts DP, Bhatnagar PK et al. (2000) Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic. J Med Chem; 43:22–26.

    Article  CAS  Google Scholar 

  3. Fox S. (2007) Throughput Screening 2007: New Strategies, Success Rates, and Use of Enabling Technologies (HighTech Business Decisions Market report: http://www.hightechdecisions.com/reports.html).

  4. Macarrón R. (2006) Critical review of the role of HTS in drug discovery. Drug Discov Today; 11:277–279.

    Article  Google Scholar 

  5. Gonzalez JE, Oades K, Leychkis Y, Harootunian A, Negulescu PA. (1999) Cell-based assays and instrumentation for screening ion-channel targets. Drug Discov Today; 4:431–439.

    Article  CAS  Google Scholar 

  6. Schroeder KS, Neagle BD. (1996) FLIPR: A new instrument for accurate, high throughput optical screening. J Biomol Screen; 1:75–80.

    Article  CAS  Google Scholar 

  7. Shoichet BK. (2006) Screening in a spirit haunted world. Drug Discov Today; 11:607–615.

    Article  CAS  Google Scholar 

  8. Inglese J, Johnson RL, Simeonov A et al. (2007) High-throughput screening assays for the identification of chemical probes. Nat Chem Biol; 3:466–479.

    Article  CAS  Google Scholar 

  9. Eggeling C, Brand L, Ullmann D, Jäger S. (2003) Highly sensitive fluorescence detection technology currently available for high throughput screening. Drug Discov Today; 8:632–641.

    Article  CAS  Google Scholar 

  10. Pope AJ, Haupts U, Moore KJ. (1999) Homogeneous fluorescence readouts for miniaturized high-throughput screening; Theory and practice. Drug Discov Today; 4:350–362.

    Article  CAS  Google Scholar 

  11. Gaudet EA, Huang KS, Zhang Y, Huang W, Mark D, Sportsman JR. (2001) A homogeneous fluorescence polarization assay adaptable for a range of protein serine/threonine and tyrosine kinases. J Biomol Screen; 8:164–175.

    Article  Google Scholar 

  12. Wu S, Liu B. (2005) Application of scintillation proximity assay in drug discovery. Biodrugs; 19:383–392.

    Article  CAS  Google Scholar 

  13. Glickman J, Wu X, Mercuri R et al. (2002) A comparison of ALPHAScreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors. J Biomol Screen; 7:3–10.

    Article  CAS  Google Scholar 

  14. Debad JD, Glezer EN, Wohlstadter JN, Sigal GB. (2004) Clinical and biological applications of ECL. In: Bard AJ (ed.), Electrogenerated Chemiluminescence. New York: Marcel Dekker, pp. 43–78.

    Google Scholar 

  15. Rich RL, Myszka DG. (2007) Higher-throughput, label-free, real-time molecular interaction analysis. Anal Biochem; 361:1–6.

    Article  CAS  Google Scholar 

  16. Gabriel D, Vernier M, Pfeifer MJ, Dasen B, Tenaillon L, Bouhelal R. (2003) High throughput screening technologies for direct cyclic AMP measurement. Assay Drug Dev Technol; 1:291–303.

    Article  CAS  Google Scholar 

  17. Zheng W, Spencer R, Kiss L. (2004) High throughput assay technologies for ion channel drug discovery. Assay Drug Dev Technol; 2:543–552.

    Article  CAS  Google Scholar 

  18. Terstappen GC. (2005) Ion channel screening technologies today. Drug Discov Today: Technol; 2:133–140.

    Article  CAS  Google Scholar 

  19. Hill SJ, Baker JG, Rees S. (2001) Reporter-gene systems for the study of G-protein-coupled receptors. Curr Opin Pharmacol; 1:526–532.

    Article  CAS  Google Scholar 

  20. Fan F, Wood KV. (2007) Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol; 5:127–136.

    Article  CAS  Google Scholar 

  21. Poulsen F, Jensen KB. (2007) A luminescent oxygen channeling immunoassay for the determination of insulin in human plasma. J Biomol Screen; 12:240–247.

    Article  CAS  Google Scholar 

  22. Assay Guidance Manual Version 4.1. Eli Lilly and Company and NIH Chemical Genomics Center (2005) (Accessed December 14, 2007, at http://www.ncgc.nih.gov/guidance/manual_toc.html.).

  23. Cheng YC, Prussof W. (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol; 22:3099–3108.

    Article  CAS  Google Scholar 

  24. Bush K. (1983) Screening and characterization of enzyme inhibitors as drug candidates. Drug Metab Reviews; 14:689–708.

    Article  CAS  Google Scholar 

  25. Macarron R, Mensah L, Cid C et al. (2000) A homogeneous method to measure aminoacyl-tRNA synthetase aminoacylation activity using scintillation proximity assay technology. Anal Biochem; 284:183–190.

    Article  CAS  Google Scholar 

  26. Tipton KF. (1980) Kinetics and enzyme inhibition studies. In: Sandler M (ed.), Enzyme Inhibitors as Drugs. Baltimore: University Park Press, pp. 1–23.

    Google Scholar 

  27. Burt D. (1986) Receptor binding methodology and analysis. In: O'Brien RA (ed.), Receptor Binding in Drug Research. New York: Decker, pp. 4–29.

    Google Scholar 

  28. Gupta S, Indelicato S, Jethwa V et al. (2007) Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics. J Immunol Methods; 321:1–18.

    Article  CAS  Google Scholar 

  29. Kost TA, Condreay JP, Ames RS, Rees S, Romanos MA. (2007) Implementation of BacMam virus gene delivery technology in a drug discovery setting. Drug Discov Today; 12:396–403.

    Article  CAS  Google Scholar 

  30. Lundholt B, Scudder K, Pagliaro L. (2003) A simple technique for reducing edge effect in cell-based assays. J Biomol Screen; 8:566–570.

    Article  CAS  Google Scholar 

  31. Lutz MW, Menius JA, Choi TD et al. (1996) Experimental design for high-throughput screening. Drug Discov Today; 1:277–286.

    Article  CAS  Google Scholar 

  32. Taylor P, Stewart F, Dunnington DJ et al. (2000) Automated Assay Optimization with Integrated Statistics and Smart Robotics. J Biomol Screen; 5:213–225.

    Article  CAS  Google Scholar 

  33. Zhang JH, Chung TDY, Oldenburg KR. (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen; 4:67–73.

    Article  Google Scholar 

  34. Iversen PW, Eastwood BJ, Sittampalam GS, Cox KL. (2006) A comparison of assay performance measures in screening assays: signal window, Z' factor, and assay variability ratio. J Biomol Screen; 11:247–252.

    Article  CAS  Google Scholar 

  35. Barnett V. (1974) Elements of Sampling Theory. London: The English Universities Press, pp. 42–46.

    Google Scholar 

Download references

Acknowledgments

The authors are grateful to the many colleagues at GlaxoSmithKline, which helped over the years to shape the screening process and to build the collective knowledge succinctly described in this introduction.

Author information

Authors and Affiliations

  1. Molecular Discovery Research, GlaxoSmithKline, Collegeville, PA, USA

    Ricardo Macarrón & Robert P. Hertzberg

Authors
  1. Ricardo Macarrón
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert P. Hertzberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2009 Humana Press, a part of Springer Science+Business Media, LLC

    About this protocol

    Cite this protocol

    Macarrón, R., Hertzberg, R.P. (2009). Design and Implementation of High-Throughput Screening Assays. In: Janzen, W., Bernasconi, P. (eds) High Throughput Screening. Methods in Molecular Biology, vol 565. Humana Press. https://doi.org/10.1007/978-1-60327-258-2_1

    Download citation

    • DOI: https://doi.org/10.1007/978-1-60327-258-2_1

    • Published:

    • Publisher Name: Humana Press

    • Print ISBN: 978-1-60327-257-5

    • Online ISBN: 978-1-60327-258-2

    • eBook Packages: Springer Protocols

    Publish with us

    Policies and ethics

    Search

    Navigation